Bleeding Complications in Patients Undergoing Percutaneous Spinal Cord Stimulator Trials and Implantations | Zendy

Susan M. Moeschler | Zendy; Nafisseh S. Warner | Zendy; Tim J. Lamer | Zendy; Markus A. Bendel | Zendy; Matthew A. Warner | Zendy; Jason S. Eldrige | Zendy; William D. Mauck | Zendy; Halena M. Gazelka | Zendy; Daryl J. Kor | Zendy; Bryan C. Hoelzer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bleeding Complications in Patients Undergoing Percutaneous Spinal Cord Stimulator Trials and Implantations

Author(s) -

Susan M. Moeschler,

Nafisseh S. Warner,

Tim J. Lamer,

Markus A. Bendel,

Matthew A. Warner,

Jason S. Eldrige,

William D. Mauck,

Halena M. Gazelka,

Daryl J. Kor,

Bryan C. Hoelzer

Publication year - 2016

Publication title -

pain medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnw124

Subject(s) - medicine , spinal cord stimulator , aspirin , hematoma , percutaneous , surgery , complication , epidural hematoma , retrospective cohort study , neurosurgery , anesthesia , spinal cord , spinal cord stimulation , psychiatry

Spinal cord stimulators (SCS) are indicated for the management of multiple pain states with strong evidence. Recent guidelines recommend discontinuing aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) for the described procedures. The goal of this investigation is to assess the rate of bleeding and neurologic sequelae in patients undergoing SCS trials and implantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research